Entropia Signs Novartis as First European Test Site for Distributed Computing Platform | GenomeWeb

NEW YORK, Aug. 28 – Entropia, of San Diego, on Tuesday said that Swiss pharmaceutical company Novartis will evaluate its PC-based distributed computing technology under a two-month pilot study.

Under the program, Novartis, with headquarters in Basel, will assess the ability of the technology—which harnesses spare cycles available from an existing network of PCs—to meet the computational demands of its drug-discovery efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.